Form 13-F position report

AVROBIO INC COM (DE)

Reported by New Leaf Venture Partners L L C

AVRO CUSIP 05455M100 Manager CIK 0001631614

Reported 0 shares, down 315,550 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 21 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2020-12-31 4399000
2021-03-31 4004000
2021-06-30 2805000
2021-09-30 1761000
2021-12-31 1215000
2022-03-31 417000
2022-06-30 290000
2022-09-30 203000
2022-12-31 224956
2023-03-31 315550
2023-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for AVROBIO INC COM (DE) held by New Leaf Venture Partners L L C.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2023 Reduced 0 -315,550 (-100.0%) 0 $0 2023-08-10
Q1 2023 Unchanged 315,550 0 (0.0%) 0.26% $315,550 2023-05-11
Q4 2022 Unchanged 315,550 0 (0.0%) 0.16% $224,956 2023-02-06
Q3 2022 Unchanged 315,550 0 (0.0%) 0.12% $203,000 2022-11-10
Q2 2022 Unchanged 315,550 0 (0.0%) 0.19% $290,000 2022-08-09
Q1 2022 Unchanged 315,550 0 (0.0%) 0.21% $417,000 2022-05-06
Q4 2021 Unchanged 315,550 0 (0.0%) 0.44% $1,215,000 2022-02-11
Q3 2021 Unchanged 315,550 0 (0.0%) 0.51% $1,761,000 2021-11-12
Q2 2021 Unchanged 315,550 0 (0.0%) 0.72% $2,805,000 2021-08-12
Q1 2021 Unchanged 315,550 0 (0.0%) 0.93% $4,004,000 2021-05-12
Q4 2020 Unchanged 315,550 0 (0.0%) 1.02% $4,399,000 2021-02-10
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

55 managers reported AVROBIO INC COM (DE) for Q2 2023.

Managers reporting AVROBIO INC COM (DE) in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Atlas Venture Life Science Advisors LLC Unchanged 4,541,381 0 0.54% $4,314,766 7 qtrs
TANG CAPITAL MANAGEMENT LLC Added 2,705,000 +2,667,387 0.38% $2,570,021 2 qtrs
GMT CAPITAL CORP Reduced 2,412,015 -1,945,844 0.09% $2,291,655 10 qtrs
ACADIAN ASSET MANAGEMENT LLC Unchanged 1,770,147 0 < 0.01% $1,680,000 8 qtrs
VANGUARD GROUP INC Unchanged 1,181,134 0 < 0.01% $1,122,196 21 qtrs
MORGAN STANLEY Added 1,049,270 +846,425 < 0.01% $996,911 21 qtrs
Aisling Capital Management LP Unchanged 1,009,779 0 0.47% $959,391 19 qtrs
FARALLON CAPITAL MANAGEMENT LLC Reduced 899,700 -2,216,300 < 0.01% $854,805 21 qtrs
BlackRock Inc Reduced 633,036 -760,333 < 0.01% $601,447 21 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 562,567 -10,800 < 0.01% $534,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 10, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.